Abstract
The potential role of copper (Cu2+) in modulating the activity of nitric oxide synthase (NOS) and guanylyl cyclase (GC) was investigated by use of diethyldithiocarbamic acid (DEDCA), a high affinity Cu2+ chelator.
DEDCA 100 μM inhibited sodium nitroprusside (SNP; 0.005–10 μM)-evoked relaxation of rat isolated aortic rings precontracted with 3 μM phenylephrine (PE). A lower concentration of DEDCA (10 μM) did not significantly attenuate SNP-evoked responses but did inhibit relaxation to the endothelium-dependent dilator, A23187 (0.01–10 μM).
The presence of 100 μM Cu2+, but not 100 μM Fe2+, alone enhanced A23187- and SNP-evoked relaxation of aortae precontracted with PE.
The inhibitory effect of DEDCA on SNP- and A23187-induced relaxation was reversed by equimolar concentrations of Cu2+ but not Fe2+, indicating that DEDCA does not act via removal of haem-iron from the NOS and GC complexes.
Superoxide dismutase (30 μ ml−1) was without effect on the inhibition of DEDCA relaxation induced by either SNP or A23187 in aortae precontracted with PE.
When assessed by radioimmunoassay, DEDCA inhibited SNP- and A23187-stimulated cyclic GMP formation with IC50 values of 0.5 μM and 50 μM, respectively.
These data demonstrate that Cu2+ plays a role in controlling NOS and GC activity in the rat aorta.
Keywords: Copper, nitric oxide synthase, guanylyl cyclase, cardiovascular disease
Full Text
The Full Text of this article is available as a PDF (365.2 KB).